Evofem Biosciences Inc (OTCPK:EVFM)

$ 0.01 0.00004 (0.4%) Market Cap: 1.00 Mil Enterprise Value: 50.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Evofem Biosciences Inc Investor Call Transcript
Aug 11, 2022
Q2 2022 Evofem Biosciences Inc Earnings Call Transcript
Aug 04, 2022

$112.25 (+3.22%)

Earnings
Q1 2022 Evofem Biosciences Inc Earnings Call Transcript
May 04, 2022

$308.62 (-0.24%)

Earnings
Q4 2021 Evofem Biosciences Inc Earnings Call Transcript
Mar 03, 2022

$918.75 (-8.12%)

Earnings
Q3 2021 Evofem Biosciences Inc Earnings Call Transcript
Nov 15, 2021

$1246.87 (-0.75%)

Earnings
Evofem Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021
Q2 2021 Evofem Biosciences Inc Earnings Call Transcript
Aug 11, 2021

$1586.05 (-0.24%)

Earnings
Evofem Biosciences Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2021
Q1 2021 Evofem Biosciences Inc Earnings Call Transcript
May 06, 2021

$2287.49 (-5.43%)

Earnings
Q4 2020 Evofem Biosciences Inc Earnings Call Transcript
Mar 04, 2021

$6131.22 (-9.17%)

Earnings
Evofem Biosciences Inc at H C Wainwright BioConnect Conference (Virtual) Transcript
Jan 11, 2021
Q3 2020 Evofem Biosciences Inc Earnings Call Transcript
Nov 09, 2020

$4387.48 (-4.49%)

Earnings
Evofem Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 18, 2020
Q2 2020 Evofem Biosciences Inc Earnings Call Transcript
Aug 04, 2020

$5662.47 (-5.63%)

Earnings
Evofem Biosciences Inc to Discuss the FDA Approval of Phexxi - Call Transcript
May 26, 2020
Q1 2020 Evofem Biosciences Inc Earnings Call Transcript
May 06, 2020

$9824.95 (+2.54%)

Earnings
Q4 2019 Evofem Biosciences Inc Earnings Call Transcript
Mar 12, 2020

$7443.71 (-23.06%)

Earnings
Q3 2019 Evofem Biosciences Inc Earnings Call Transcript
Nov 07, 2019

$9543.7 (-0.20%)

Earnings
Q2 2019 Evofem Biosciences Inc Earnings Call Transcript
Aug 06, 2019

$9693.7 (-4.61%)

Earnings
Evofem Biosciences Inc at ROTH Conference - Fireside Chat Transcript
Mar 19, 2019
Q4 2018 Evofem Biosciences Inc Earnings Call Transcript
Mar 01, 2019

$6843.72 (-12.05%)

Earnings

Evofem Biosciences Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 04, 2021 / 02:30PM GMT

Release Date Price: $1622.62 (-1.76%)

Transcript

Megan Dorogi

(Trades, Portfolio) LLC - Analyst

Good morning everyone. My name is Megan Dorogi; I'm an analyst in Jefferies' healthcare investment banking. It is my pleasure to introduce Saundra Pelletier, Chief Executive Officer of Evofem Biosciences, to present at our virtual healthcare conference. Without further ado, I will pass it to Saundra.

Saundra Pelletier

Evofem Biosciences, Inc. - CEO and Interim Chair of the Board

Great, thank you so much, Megan. I'm thrilled to be here today to share with you what we are doing, Evofem Biosciences, to revolutionize sex and reproductive health care for women. And at this moment in time, in my opinion, there is nothing more important than quality of life for everyone, but how we are impacting that is through safe,

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.